Traversing the genomic landscape of prostate cancer from diagnosis to death

Nat Genet. 2012 May 29;44(6):613-4. doi: 10.1038/ng.2301.

Abstract

The clinical spectrum of prostate cancer ranges from curable, local disease to widely metastatic, lethal cancer. Two new prostate cancer genome studies provide the first glimpse at both ends of this spectrum.

Publication types

  • News
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Hepatocyte Nuclear Factor 3-alpha / genetics*
  • Humans
  • Male
  • Mediator Complex / genetics*
  • Microtubule-Associated Proteins / genetics*
  • Mutation*
  • Prostatic Neoplasms / genetics*

Substances

  • FOXA1 protein, human
  • Hepatocyte Nuclear Factor 3-alpha
  • MAP6 protein, human
  • MED12 protein, human
  • Mediator Complex
  • Microtubule-Associated Proteins